The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned ...

U.S. FDA Approves NUBEQA® (darolutamide) to Treat Patients with Metastatic Castration-Sensitive Prostate Cancer ...

Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.

China is developing reusable rockets to launch in 2025 and 2026. See the 'net' technology they will use to catch the booster ...

The Space Launch System rocket's RS-25 engine was fired up for the “final round of certification testing ahead of production ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) on Tuesday announced an update related to RP-A501, its investigational gene therapy ...

Rocket CRM, a SaaS platform designed to help businesses manage and optimize their customer interactions, has introduced a ...

A voluntary recall affects salads and salsas made with cucumbers linked to a Salmonella outbreak, according to the FDA.

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

A New Jersey biotech company has paused a gene therapy trial after a participant had an unexpected adverse event and later died from a sudden, severe infection.  Rocket Pharmaceuticals said the ...